Rationale and design of the <it>CAPAMIS </it>study: Effectiveness of pneumococcal vaccination against community-acquired pneumonia, acute myocardial infarction and stroke

Rationale and design of the <it>CAPAMIS </it>study: Effectiveness of pneumococcal vaccination against community-acquired pneumonia, acute myocardial infarction and stroke

<p>Abstract</p> <p>Background</p> <p>The 23-valent polysaccharide pneumococcal vaccine (PPV-23) is recommended for elderly and high-risk people, although its effectiveness is controversial. Some studies have reported an increasing risk of acute vascular events among pat...

Full description

Bibliographic Details
Main Authors:	Salsench Elisabet, de Diego Cinta, Ochoa-Gondar Olga, Hospital-Guardiola Inmaculada, Vila-Corcoles Angel, Raga Xavier, Fuentes-Bellido Cruz M
Format:	Article
Language:	English
Published:	BMC 2010-01-01
Series:	BMC Public Health
Online Access:	http://www.biomedcentral.com/1471-2458/10/25

Similar Items

Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up
by: Vila-Corcoles Angel, et al.
Published: (2012-03-01)

Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
by: Salsench Elisabet, et al.
Published: (2010-03-01)

Drug-resistance in Streptococcus pneumoniae isolates among Spanish middle aged and older adults with community-acquired pneumonia
by: Raga-Luria Xavier, et al.
Published: (2009-03-01)

The burden of community-acquired pneumonia in the elderly: the Spanish EVAN-65 Study
by: Grive Montserrat, et al.
Published: (2008-06-01)

Evaluating clinical effectiveness of 13-valent pneumococcal conjugate vaccination against pneumonia among middle-aged and older adults in Catalonia: results from the EPIVAC cohort study
by: Angel Vila-Corcoles, et al.
Published: (2018-04-01)

Incidencia y características clínicas de las neumonías tratadas ambulatoriamente en las personas mayores de 65 años del área de Tarragona-Valls. 2002-2005
by: Angel Vila Córcoles, et al.
Published: (2009-01-01)

Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia
by: Grossi Paolo, et al.
Published: (2005-11-01)

Prevention of Community-Acquired Pneumonia with Available Pneumococcal Vaccines
by: Nicola Principi, et al.
Published: (2016-12-01)

Prevalence of high, medium and low-risk medical conditions for pneumococcal vaccination in Catalonian middle-aged and older adults: a population-based study
by: O. Ochoa-Gondar, et al.
Published: (2017-06-01)

Pneumococcal aetiology and serotype distribution in paediatric community-acquired pneumonia.
by: Iris De Schutter, et al.
Published: (2014-01-01)

Evolution of vaccination rates after the implementation of a free systematic pneumococcal vaccination in Catalonian older adults: 4-years follow-up
by: Ansa Xabier, et al.
Published: (2006-09-01)

Enfermedad neumocócica en el adulto: niveles de riesgo y recomendaciones de vacunación
by: Angel Vila-Córcoles, et al.
Published: (2017-02-01)

Incidencia de neumonía neumocócica: el sesgo de la fuente de información
by: Ángel Vila Córcoles, et al.
Published: (2005-01-01)

The potential role of pneumococcal conjugate vaccine in reducing acute respiratory inflammation in community-acquired pneumococcal pneumonia
by: Ching-Fen Shen, et al.
Published: (2020-08-01)

Prognostic value of pneumococcal urinary antigen test in community-acquired pneumonia.
by: Byunghyun Kim, et al.
Published: (2018-01-01)

EVALUATION OF THE EFFECTIVENESS OF PNEUMOCOCCAL VACCINES FOR PREVENTION OF COMMUNITY-ACQUIRED PNEUMONIA IN SERVICEMEN
by: S. D. Zhogolev, et al.
Published: (2018-12-01)

Health related quality of life in patients with community-acquired pneumococcal pneumonia in France
by: Luiz Flavio Andrade, et al.
Published: (2018-02-01)

Predictors of pneumococcal vaccination among older adults with pneumonia: findings from the Community Acquired Pneumonia Impact Study
by: Loeb Mark, et al.
Published: (2010-06-01)

Community acquired paediatric pneumonia; experience from a pneumococcal vaccine- naive population
by: Sanath Thushara Kudagammana, et al.
Published: (2020-08-01)

Twenty-year trend in mortality among hospitalized patients with pneumococcal community-acquired pneumonia.
by: Catia Cillóniz, et al.
Published: (2018-01-01)

Impact of the pneumococcal 10-valent vaccine on reducing hospitalization for community-acquired pneumonia in children
by: Sandra Rodrigues da Silva, et al.

Overview of Community-Acquired Pneumonia and the Role of Inflammatory Mechanisms in the Immunopathogenesis of Severe Pneumococcal Disease
by: Helen C. Steel, et al.
Published: (2013-01-01)

COVID19-related and all-cause mortality risk among middle-aged and older adults across the first epidemic wave of SARS-COV-2 infection: a population-based cohort study in Southern Catalonia, Spain, March–June 2020
by: Angel Vila-Corcoles, et al.
Published: (2021-10-01)

Influence of pneumococcal vaccination on the hospitalization of healthy pediatric patients due to typical Community-Acquired Pneumonia
by: Ana Isabel Valdivielso Martínez, et al.
Published: (2020-09-01)

COMMUNITY-ACQUIRED PNEUMONIA PNEUMOCOCCAL ETIOLOGY AND MICROBIOLOGICAL ASPECTS OF NASOPHARYNGEAL CARRIAGE IN CHILDREN IN THE REPUBLIC OF TATARSTAN
by: L. T. Bayazitova, et al.
Published: (2017-09-01)

Vacunación antineumocócica en adultos de Cataluña: coberturas y grado de adecuación a distintas guías de recomendaciones
by: Olga Ochoa-Gondar, et al.
Published: (2018-11-01)

PECULIARITIES OF THE PNEUMOCOCCAL PNEUMONIAE IN CHILDREN
by: T. A. Daminov, et al.
Published: (2015-08-01)

Age-stratified burden of pneumococcal community acquired pneumonia in hospitalised Canadian adults from 2010 to 2015
by: Karen Green, et al.
Published: (2020-05-01)

Effect of pneumococcal conjugate vaccination on radiological findings in infants hospitalized with community acquired pneumonia in northern India
by: S. Awasthi, et al.
Published: (2020-12-01)

A model for predicting bacteremia in patients with community-acquired pneumococcal pneumonia: a retrospective observational study
by: Yasuyoshi Washio, et al.
Published: (2018-01-01)

Pneumococcal Conjugated Vaccine Reduces the High Mortality for Community-Acquired Pneumonia in the Elderly: an Italian Regional Experience.
by: Vincenzo Baldo, et al.
Published: (2016-01-01)

Decrease of Pneumococcal Community-Acquired Pneumonia Hospitalization and Associated Complications in Children after the Implementation of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Taiwan
by: Ching-Fen Shen, et al.
Published: (2021-09-01)

Influence of prior comorbidities and chronic medications use on the risk of COVID-19 in adults: a population-based cohort study in Tarragona, Spain
by: Angel Vila-Córcoles, et al.
Published: (2020-12-01)

Retrospective epidemiological study for the characterization of community- acquired pneumonia and pneumococcal pneumonia in adults in a well-defined area of Badalona (Barcelona, Spain)
by: Sicras-Mainar Antoni, et al.
Published: (2012-11-01)

A Comparison of Bacteremic Pneumococcal Pneumonia with Nonbacteremic Community-Acquired Pneumonia of Any Etiology — Results from a Canadian Multicenter Study
by: Thomas J Marrie, et al.
Published: (2003-01-01)

Epidemiological and etiological characteristics of community-acquired pneumonia in conscripts in the modern period. Comparative evaluation of the effectiveness of pneumococcal vaccines
by: P. V. Kulikov, et al.
Published: (2019-05-01)

Clinical and epidemiological characteristics of severe community-acquired pneumonia in children after introduction of the 10-valent pneumococcal vaccine
by: Lima EJF, et al.
Published: (2015-08-01)

Epididymitis associated with bacteremic pneumococcal pneumonia
by: Ilan Berlinrut, et al.
Published: (2021-01-01)

Penicillin Resistant Bacteremic Pneumococcal Pneumonia
by: Hugh G Robson
Published: (2020-12-01)

Kinase activity profiling of pneumococcal pneumonia.
by: Arie J Hoogendijk, et al.
Published: (2011-04-01)

Cannot write session to /tmp/vufind_sessions/sess_k8f2f0krcq2dsa5c4qsa6ms3hq